Cervical cancer kills about 300,000 women per year. study included more than 12,000 women from 13 countries, aged 16 to 26, who were not infected with either of the virus types at the beginning of trial. Half the women in the Phase III trial received three doses of Gardasil over a six-month period, while the other women obtained placebos. The women were then followed for an average of 17 months. Gardasil was 100 percent effective in preventing precancerous lesions and early-stage cancers. On the other hand, there were 21 cases among the group taking placebos. Merck licensed the vaccine technology from Australian blood products and vaccine developer CSL Ltd.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology Books - Search results of biotechnology books at Google
Cancer cells - Czech Scientists are Working to Find the Achilles‘ Heel of Cancer Cells
The first eco-friendly fluorescent artificial seed for monitoring soil temperature by using drones
Mussel-inspired adhesive builds a bond between implants and bones